85 related articles for article (PubMed ID: 10452786)
1. Contrasting properties of albuterol stereoisomers.
Page CP; Morley J
J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S31-41. PubMed ID: 10452786
[TBL] [Abstract][Full Text] [Related]
2. (R)-albuterol elicits antiinflammatory effects in human airway epithelial cells via iNOS.
Chorley BN; Li Y; Fang S; Park JA; Adler KB
Am J Respir Cell Mol Biol; 2006 Jan; 34(1):119-27. PubMed ID: 16195534
[TBL] [Abstract][Full Text] [Related]
3. The synergistic anti-asthmatic effects of glycyrrhizin and salbutamol.
Yang Y; Shi Q; Liu Z; Li RJ; Pan PW; Hou YY; Lu WG; Bai G
Acta Pharmacol Sin; 2010 Apr; 31(4):443-9. PubMed ID: 20228825
[TBL] [Abstract][Full Text] [Related]
4. The asthma-like pharmacology and toxicology of (S)-isomers of beta agonists.
Handley D
J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S69-76. PubMed ID: 10452791
[TBL] [Abstract][Full Text] [Related]
5. Levalbuterol versus albuterol for acute asthma: a systematic review and meta-analysis.
Jat KR; Khairwa A
Pulm Pharmacol Ther; 2013 Apr; 26(2):239-48. PubMed ID: 23207739
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the safety and efficacy of levalbuterol in 2-5-year-old patients with asthma.
Skoner DP; Greos LS; Kim KT; Roach JM; Parsey M; Baumgartner RA
Pediatr Pulmonol; 2005 Dec; 40(6):477-86. PubMed ID: 16193496
[TBL] [Abstract][Full Text] [Related]
7. A patient satisfaction survey comparing levalbuterol with racemic albuterol in children.
Berger WE; Ames DE; Harrison D
Allergy Asthma Proc; 2004; 25(6):437-44. PubMed ID: 15709455
[TBL] [Abstract][Full Text] [Related]
8. Levalbuterol compared with racemic albuterol in the treatment of acute asthma: results of a pilot study.
Nowak RM; Emerman CL; Schaefer K; Disantostefano RL; Vaickus L; Roach JM
Am J Emerg Med; 2004 Jan; 22(1):29-36. PubMed ID: 14724875
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of nebulized levalbuterol in stable COPD.
Datta D; Vitale A; Lahiri B; ZuWallack R
Chest; 2003 Sep; 124(3):844-9. PubMed ID: 12970007
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with levalbuterol.
Nelson HS
J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S77-84. PubMed ID: 10452792
[TBL] [Abstract][Full Text] [Related]
11. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
[TBL] [Abstract][Full Text] [Related]
12. Kinetics and distribution of the beta-adrenergic agonist salbutamol in rat brain.
Caccia S; Fong MH
J Pharm Pharmacol; 1984 Mar; 36(3):200-2. PubMed ID: 6144759
[TBL] [Abstract][Full Text] [Related]
13. Workshop report - interdisciplinary metabolomic epidemiology: the pathway to clinical translation.
Zanetti KA; Guo L; Husain D; Kelly RS; Lasky-Su J; Broadhurst D; Wheelock CE
Metabolomics; 2024 May; 20(3):60. PubMed ID: 38773013
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of the bronchodilator efficacy and adverse effects of salbutamol and hyoscine butylbromide in horses with severe asthma.
Mozo Vives B; Mainguy-Seers S; Lavoie JP
J Vet Intern Med; 2024; 38(3):1835-1841. PubMed ID: 38609079
[TBL] [Abstract][Full Text] [Related]
15. Safety of Levalbuterol Compared to Albuterol in Patients With a Tachyarrhythmia.
Lindquist DE; Cooper AA
J Pharm Technol; 2014 Feb; 30(1):13-17. PubMed ID: 34860877
[No Abstract] [Full Text] [Related]
16. Spatial Distribution of (R)-salbutamol in Rat Brain Following Nasal and Intravenous Administration Using DESI-MS.
Zhang R; Wu J; Liu S; Deng L; Hu J; Chen X; Tan W
Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31906459
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Inhaled Levalbuterol Compared to Albuterol in Horses with Recurrent Airway Obstruction.
Arroyo MG; Couëtil LL; Nogradi N; Kamarudin MM; Ivester KM
J Vet Intern Med; 2016 Jul; 30(4):1333-7. PubMed ID: 27282625
[TBL] [Abstract][Full Text] [Related]
18. Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations.
Agarwal R; Dhooria S; Aggarwal AN; Maturu VN; Sehgal IS; Muthu V; Prasad KT; Yenge LB; Singh N; Behera D; Jindal SK; Gupta D; Balamugesh T; Bhalla A; Chaudhry D; Chhabra SK; Chokhani R; Chopra V; Dadhwal DS; D'Souza G; Garg M; Gaur SN; Gopal B; Ghoshal AG; Guleria R; Gupta KB; Haldar I; Jain S; Jain NK; Jain VK; Janmeja AK; Kant S; Kashyap S; Khilnani GC; Kishan J; Kumar R; Koul PA; Mahashur A; Mandal AK; Malhotra S; Mohammed S; Mohapatra PR; Patel D; Prasad R; Ray P; Samaria JK; Singh PS; Sawhney H; Shafiq N; Sharma N; Sidhu UP; Singla R; Suri JC; Talwar D; Varma S
Lung India; 2015 Apr; 32(Suppl 1):S3-S42. PubMed ID: 25948889
[No Abstract] [Full Text] [Related]
19. Anti-inflammatory effects of levalbuterol-induced 11β-hydroxysteroid dehydrogenase type 1 activity in airway epithelial cells.
Randall MJ; Kostin SF; Burgess EJ; Hoyt LR; Ather JL; Lundblad LK; Poynter ME
Front Endocrinol (Lausanne); 2014; 5():236. PubMed ID: 25628603
[TBL] [Abstract][Full Text] [Related]
20. β2-adrenergic receptor agonists modulate human airway smooth muscle cell migration via vasodilator-stimulated phosphoprotein.
Goncharova EA; Goncharov DA; Zhao H; Penn RB; Krymskaya VP; Panettieri RA
Am J Respir Cell Mol Biol; 2012 Jan; 46(1):48-54. PubMed ID: 22210825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
